President was given an antibody cocktail, still gift evaluated in clinical trials, the targets a surface protein of the new coronavirus

President Donald Trump has maintained a stable schedule of campaign rallies, i beg your pardon may have actually exposed him come SARS-CoV-2.White residence (Tia Dufour)"s COVID-19 report is supported by the Pulitzer Center and also the Heising-Simons Foundation.

You are watching: Did trump get tested for coronavirus

On 2 October, the White house announced president Donald Trump obtained an speculative antibody treatment after a check revealed he"s infected v SARS-CoV-2. In ~ the time, the reportedly had mild COVID-19 symptoms, consisting of fever and congestion, and he was moved to Walter Reed nationwide Military medical Center. Later, the president"s medical team evidenced he had started a course of remdesivir, an antiviral drug presented to modestly aid hospitalized COVID-19 patients. Two days later, ~ above 4 October, the team revealed Trump had actually been provided a steroid generally reserved for significant COVID-19 cases, return his physician readily available optimism about a fast recovery, even arguing he might soon be discharged indigenous Walter Reed.

What is the antibody cocktail trump received?

It"s a combination of two antibodies directed versus a crucial protein the the virus that causes COVID-19, SARS-CoV-2. They tie to a an ar on the main surface spike protein that helps the virus connect to a receptor on human being cells dubbed angiotensin-converting enzyme 2. The targeted an ar is called the receptor binding domain. One antibody comes from a human who had actually recovered from a SARS-CoV-2 infection; a B cabinet that renders the antibody to be harvested native the person"s blood and also the gene for the immune protein isolated and copied. The various other antibody is from a mouse, which to be engineered to have a human being immune system, that had the spike protein injected into it.

Are there any type of data showing the cocktail works and also is safe?

Experiments in both gold hamsters and also rhesus macaques that were purposely infected with SARS-CoV-2 proved the cocktail could reduce famous levels and condition pathology.

Regeneron, the device of the cocktail, earlier last week gift preliminary data from its recurring clinical psychological in world who tested positive for SARS-CoV-2 however were asymptomatic or, in the most extreme cases, had moderate disease—a team that would show up to mirror Trump"s current condition. No severe safety involves surfaced, and also the treatment lessened viral load and shortened symptomatic an illness in patients who did not have SARS-CoV-2 antibodies at the trial"s start. It"s unclear whether the treatment deserve to prevent significant disease, but there were clues that the might: attendees who got a placebo had an ext medical visits.

A different trial is assessing the affect of the treatment on hospitalized COVID-19 patients, but Regeneron has yet to report any results from that study.

Do the preliminary clinical psychological data complement the president"s treatment scheme?

Not exactly. Trump got an 8-gram infusion the the treatment. Regeneron"s data verified a 2.4-gram infusion worked and the higher dose at reducing SARS-CoV-2 levels in people. This was widely checked out as an excellent news because monoclonals are difficult and expensive come produce, and a lower dose method more world can eventually receive it. (On 7 October, Trump"s personal physician stated the president was an adverse for SARS-CoV-2 antibodies as soon as he received the cocktail.)

Why go the president obtain the higher dose of the antibodies?

Likely the end of "an diversity of caution" by the president"s medical team, says George Yancopoulos, co-founder and also chief clinical officer of Regeneron. Yancopoulos walk not straight know why Trump"s physicians determined to usage 8 grams, yet says the company"s data show there"s "very, very limited risk" the the antibodies will reason harm at either dose. The greater dose could last longer, that said, and at part time point out in the company"s study, Regeneron did see "trends" saying the higher dose an ext powerfully beats back the virus—the firm used the amount of viral genetic material found with nose swabs together a proxy because that SARS-CoV-2 level in the entire body.

"If I had to law one patient, I"d provide the high dose," Yancopoulos says. "From a societal suggest of view and also the have to treat as many people as possible, I"d give the reduced dose."

Did Trump enhance the patients in the research who benefited from the treatment?

The Regeneron study found the therapy only operated in world who walk not have actually SARS-CoV-2 antitoxin at the start of the study. It additionally worked ideal in civilization who had greater levels of the virus. Whether the president had those antibodies and also a high viral load has actually not been made public. "I couldn"t speculate since it needs to do v an separation, personal, instance patient," Yancopoulos says.

The memorandum from the president"s doctor said Trump was receiving "Regeneron"s polyclonal antibody cocktail." space these antitoxin "polyclonal"?

No. The treatment consisted of two monoclonal antibodies—meaning every was developed by making identical copies, or clones, of one antibody gene in a solitary B cell. Polyclonal antibody cocktails describe antibodies made by mixtures of B cells.

What to be the regulatory mechanism that permitted the president to receive the experimental Regeneron antibodies?

The antitoxin are generally only obtainable to human being who take part in clinical trials. Trump theoretically can have enrolled in the recurring treatment research that report preliminary data last week, however that trial randomly assigns fifty percent the attendees to obtain the antibodies; the other half serves as a regulate group and also receives infusions of one inactive placebo. A U.S. Food and also Drug management (FDA) regulation referred to as "expanded access"—technically known as 21 CFR 312.310—allows doctors to inquiry "compassionate use" of speculative treatments with an "investigational brand-new drug" pathway offered for individual patient or because that emergencies. "These space designed come be supplied in these rare and also special circumstances," Yancopoulos says. "This is no the first time we"ve excellent compassionate usage for this monoclonal antibodies. This is not a system for extensive distribution."

Could Regeneron"s monoclonal antibody treatment become much more widely obtainable through FDA"s emergency use authorization (EUA) pathway?

Yes. Both Regeneron and Eli Lilly, which likewise reported encouraging preliminary clinical trial data critical month native a single SARS-CoV-2 monoclonal antibody, are pointing out the opportunity of one EUA through FDA. Lilly reported indicators that that antibody lessened the need for hospitalization, but as with Regeneron, too few participants have actually so far end up being seriously okay to reach a convincing conclusion to this an essential question.

Did Regeneron use aborted fetal cell to do the monoclonal antibodies the Trump received?

No. Although the monoclonal antibodies infused into Trump were not made native or in fetal cells, Regeneron did build that treatment through the assist of a long-lived heat of cells established from the kidney of a fetus electively aborted in the Netherlands roughly 1972. The firm relied ~ above those widely provided cells, recognized as HEK-293 cells, to do mimics that the coronavirus spike protein. Researchers supplied these protein to check the potential of antibodies discovered in COVID-19 patient or made in mice v a humanlike immune device (see early question). The antibodies selected because that the company"s cocktail, however, were climate mass produced in nonfetal cells. The creation of the humanized mice likewise did not count on HEK-293 cell or various other cells indigenous aborted fetuses or human being embryos. Regeneron scientists detail their methods in the supplementary product to this file published in in August.

What"s the proof for utilizing remdesivir in COVID-19 patients?

Remdesivir is an antiviral drug occurred by Gilead gendergeek.orgs, initially to act the hepatitis C virus. The did not perform well versus that virus but has been tried versus Ebola and also other viruses, after showing some activity in cells and also animal models. The drug inhibits a viral enzyme used for replication the the pathogen. Previously this year, it prove a usually clinical benefit in a trial with hospitalized COVID-19 patients, leading FDA to give Gilead an EUA because that the drug. That EUA has because been expanded for use in patients v mild condition although its advantage in castle is no clear. The drug has end up being widely offered for COVID-19 patient despite continuing skepticism that it has actually a significant clinical benefit. Since it and also the monoclonal antitoxin target various parts the the virus, administering them with each other may have a synergistic effect. One COVID-19 clinical psychological is testing remdesivir and Lilly"s antibody, for example.

Why was a steroid added to his treatment?

On 4 October, Sean Conley, the White home physician, claimed in a push conference the Trump had likewise been started on the steroid dexamethasone. The medicine dampens the body"s immune an answer and have the right to keep that from wreaking havoc in the late stages of COVID-19. It is the only treatment so much that has been presented to mitigate the mortality in patient with significant COVID-19, however there are some indications the it might actually be harmful if offered too early in the condition course. In the joined Kingdom"s recovery trial there to be a clear advantage for patients requiring oxygen or ventilation but not for other patients. Conley claimed Trump had experienced "two illustration of transient fall in his oxygen saturation." Independent doctors were fast to allude out that dexamethasone deserve to have significant side results including agitation, paranoia, and even psychosis.

Is the president receiving any type of other COVID-19 treatments?

The statement exit on 2 October through the president"s doctor said that in enhancement to the antibodies, trump card "has been taking zinc, vitamin D, famotidine, melatonin and also a day-to-day aspirin." that wording leaves unclear even if it is he was acquisition those substances prior to his diagnosed infection. Notably, the statement does not suggest whether Trump was or is acquisition hydroxychloroquine, the antimalarial that controversially driven as a COVID-19 treatment.

Famotidine has been suggested to be a therapy for COVID-19, however it"s likewise a well-known heartburn remedy, sold widely under the name Pepcid. A clinical trial experimentation it in hospitalized COVID-19 patients in brand-new York was no able to recruit sufficient patients to correctly evaluate that is impact. The Feinstein academy for clinical Research, which initiated the trial, released a explain on 2 October citing evidence it was useful for COVID-19 but also saying, "We have actually yet come prove efficacy." The institute says it"s "eagerly awaiting" FDA approval the a trial that will certainly evaluate whether famotidine can help people who are not hospitalized.

This story was initially published ~ above 2 October at 9:25 p.m.

*Update, 3 October, 1:20 p.m.: Information about Trump"s usage of remdesivir was added to the story.

*Update, 5 October, 9:15 a.m.: Information about Trump"s use of dexamethasone was included to the story.

See more: Did Leah Remini Win An Emmy, Leah Remini: Scientology And The Aftermath

*Update, 7 October, 3:55 p.m.: Information around the Regeneron therapy was included to this story.